BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6997177)

  • 1. Strep vaccine.
    Fox EN
    Hosp Pract; 1980 Feb; 15(2):23-4. PubMed ID: 6997177
    [No Abstract]   [Full Text] [Related]  

  • 2. Resurgence of severe streptococcal diseases: prospects for a streptococcal vaccine.
    Markowitz M
    Int J Tissue React; 1993; 15(3):105-7. PubMed ID: 8188446
    [No Abstract]   [Full Text] [Related]  

  • 3. [Primary prevention of rheumatism: the status and outlook (vaccine)].
    Rotta Y
    Ter Arkh; 1985; 57(11):97-100. PubMed ID: 3909476
    [No Abstract]   [Full Text] [Related]  

  • 4. Streptococcal vaccines revisited.
    Stollerman GH
    J Lab Clin Med; 1978 Jun; 91(6):872-80. PubMed ID: 77303
    [No Abstract]   [Full Text] [Related]  

  • 5. [Curative and prophylactic immunomodulation by vaccination in mucocutaneous streptococcal infections].
    Topciu V; Teodorescu M; Sedan D
    Bacteriol Virusol Parazitol Epidemiol; 1996; 41(1-2):71-3. PubMed ID: 8963122
    [No Abstract]   [Full Text] [Related]  

  • 6. [Further study of the prevention of streptococcal infections in experiments on monkeys].
    Keller V; Dzhikidze EK; Voskanian NA; Kiunemund O; Knol' G
    Vestn Akad Med Nauk SSSR; 1986; (3):66-8. PubMed ID: 3518270
    [No Abstract]   [Full Text] [Related]  

  • 7. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
    Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
    Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for a group A streptococcal vaccine.
    McMillan DJ; Chhatwal GS
    Curr Opin Mol Ther; 2005 Feb; 7(1):11-6. PubMed ID: 15732524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoprophylaxis of streptococcal infections in suckling piglets--testing of a streptococcal-staphylococcal adsorbate vaccine for vaccination of sows in advanced pregnancy].
    Schöll W; Bernhard J; Köhler B; Senf W; Zabke J; Glaser F; Barbe J
    Arch Exp Veterinarmed; 1983 Jul; 37(4):511-26. PubMed ID: 6651439
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinical, laboratory and treatment aspects in streptoderma].
    Ungureanu V; Mihalcu F; Dumitrache A; Iacob A; Buzatu S
    Bacteriol Virusol Parazitol Epidemiol; 1995; 40(1):17-23. PubMed ID: 7579943
    [No Abstract]   [Full Text] [Related]  

  • 11. [Perspectives on the development of a streptococcal vaccine].
    Evseev VA
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Feb; (2):9-16. PubMed ID: 57684
    [No Abstract]   [Full Text] [Related]  

  • 12. Group A streptococcus vaccine may be ready for phase I clinical trials in late 1989.
    Raymond CA
    JAMA; 1988 Nov; 260(19):2778. PubMed ID: 3054182
    [No Abstract]   [Full Text] [Related]  

  • 13. Group A streptococcal vaccines.
    Pichichero ME
    JAMA; 2004 Aug; 292(6):738-9. PubMed ID: 15304473
    [No Abstract]   [Full Text] [Related]  

  • 14. Homologous and heterologous protection of mice with group A streptococcal M protein vaccines.
    Wittner MK; Fox EN
    Infect Immun; 1977 Jan; 15(1):104-8. PubMed ID: 319054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strep vaccine: how close?
    Beachey EH; Stollerman GH; Bisno AL
    Hosp Pract; 1979 Nov; 14(11):49-57. PubMed ID: 500078
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.
    McNeil SA; Halperin SA; Langley JM; Smith B; Warren A; Sharratt GP; Baxendale DM; Reddish MA; Hu MC; Stroop SD; Linden J; Fries LF; Vink PE; Dale JB
    Clin Infect Dis; 2005 Oct; 41(8):1114-22. PubMed ID: 16163629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development.
    Areschoug T; Carlsson F; Stålhammar-Carlemalm M; Lindahl G
    Vaccine; 2004 Dec; 22 Suppl 1():S9-S14. PubMed ID: 15576204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress towards developing a vaccine for group A streptococcus based on the M protein.
    Good MF
    Intern Med J; 2002 Apr; 32(4):132-3. PubMed ID: 11951921
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiology and prevention of streptococcal infections].
    Ivan A; Groll M; Buzdugan I; Mitroi I
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):61-5. PubMed ID: 2814031
    [No Abstract]   [Full Text] [Related]  

  • 20. StreptAvax (ID Biomedical).
    McMillan D
    Curr Opin Investig Drugs; 2006 Feb; 7(2):186-90. PubMed ID: 16499290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.